News and events

LaBaer advances disease research, claims important award

July 15, 2016

Josh LaBaer, M.D., PhD., a leading researcher in the rapidly expanding field of proteomics, has just been awarded the 2016 Translational Proteomics Award from the Human Proteome Organization (or HUPO). The prestigious award recognizes professor LaBaer’s distinguished scientific achievements in the field of translational proteomics science. HUPO is an international scientific organization promoting proteomics through international cooperation and collaboration, fostering the development of...

From worms to cancer cures

July 5, 2016

The path from roundworm genes to curing cancer isn’t an easy one. But a handful of students and faculty at Arizona State University are joining forces to increase our understanding of how small biological changes in genes can influence the development, diagnosis and treatment of cancer. Two faculty laboratories within ASU’s Virginia G. Piper Center for Personalized Diagnostics — and the students who work there — are fusing fundamental science with clinical research to create more...

Mathematical and Computational Models of Cancer and The Immune System

June 30, 2016

Diego Chowell, Graduate Research Assistant, Biodesign Institute Virginia G. Piper Center for Personalized Diagnostics The immune system plays a dual role during neoplastic progression. It can suppress tumor growth by eliminating cancer cells, and also promote neoplastic expansion by either selecting for tumor cells that are fitter to survive in an immunocompetent host or by establishing the right conditions within the tumor microenvironment.  This is a dissertation defense, hosted by...

ASU reaches next milestone in multi-million dollar program to develop an automated, high-throughput diagnostic test for estimating absorbed radiation

June 15, 2016

Arizona State University’s Biodesign Institute announced today it is entering a new, $7M phase of a multi-million, multi-institutional development project to produce a diagnostic test to measure an individual’s level of absorbed radiation in the event of an unplanned radiological or nuclear event. Currently, there is no U.S. Food and Drug Administration cleared or approved, high-throughput system to measure the radiation dose absorbed by individuals within a large population. The ASU...

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

International collaboration reaches milestone in curating new resource for unraveling human disease

February 25, 2016

Gene bank collection now totals 80 percent of all human protein-coding genes, collaboration reports An international collaboration of organizations, including Arizona State University’s Biodesign Institute and the Dana-Farber Cancer Institute, has reached a milestone in creating a library of complete genetic blueprints for the thousands of different proteins in human cells, called the human proteome. The collection – consisting of open-reading frames (ORFs), the portions of genes that...

BioPolicy Summit tackles reproducibility of science issues

February 11, 2016

To err is human, even for one of the most number crunching, rigorous and truth seeking of all activities: science. The issue of errors in science --- irreproducible research --- was recently a focal point for a national discussion when the Global Biological Standards Institute (GBSI) hosted its 2016 BioPolicy Summit. The 2016 GBSI Summit—“Research Reproducibility: Innovative Solutions to Drive Quality” welcomed premiere life science thought leaders, including Arizona State University...

LaBaer featured panelist at BioPolicy Summit on research reproducibility

February 2, 2016

ASU Biodesign Institute interim executive director Dr. Joshua LaBaer, MD, PhD, will be headed to the nation's capital next week to participate in an esteemed panel of top bioscience leaders as part of the 2016 Global BioPolicy Summit.  On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality welcomes LaBaer...

ASU names LaBaer interim executive director of the Biodesign Institute

January 13, 2016

Dr. Joshua L. LaBaer, a leading researcher in cancer and personalized medicine, has been named interim executive director for the Biodesign Institute at Arizona State University.   “LaBaer’s leadership will ensure that we continue our progress toward establishing the Biodesign Institute as a world-class research institute focused on solving key societal challenges in health, sustainability and national security,” said Sethuraman Panchanathan, senior vice president of ASU’s Office...

New ASU worldwide resource for exploring genes’ hidden messages

December 11, 2015

After a decade-long $3 billion international effort, scientists heralded the 2001 completion of the human genome as a moon landing achievement for biology and the key to finally solving intractable diseases like cancer. But it turns out this was only the end of the beginning, with a much greater complexity to life revealed by the roughly 20,000 genes found within the human genome. For one, most diseases are incredibly complex, with very few caused by a single gene mutation. Rather, the more...